Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05480904 · ClinicalTrials.gov registry record
Characterizing Sleep Among Long-term Survivors of Childhood Cancer
A clinical trial of Solid Tumor and ALL, Adult, sponsored by St. Jude Children's Research Hospital.
- Recruiting
- Registry status
- 120
- Enrollment target
- 1
- Study location
NCT05480904 is a study of Solid Tumor and ALL, Adult that is actively recruiting participants, run by St. Jude Children's Research Hospital. The registered enrollment target is 120 participants, below the 221-participant average among 196 other Solid Tumor trials with a reported enrollment target (46% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05480904, a study of Solid Tumor and ALL, Adult, is actively recruiting participants, sponsored by St. Jude Children's Research Hospital.
- RECRUITING
- Registry status
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
The patients are being asked to take part in this clinical trial because they received cancer treatment as a child at St. Jude. The study comprehensively examines sleep among three distinct diagnostic groups of survivors in the SJLIFE cohort: ALL, CNS tumors, and non-CNS solid tumors. Primary Objective The primary aim of this protocol is to estimate the prevalence of various sleep disorders among long-term survivors of childhood ALL, CNS tumors, and non- CNS solid tumors. Exploratory Objective The exploratory objective of the study is to explore associations between the prevalence of sleep disorders and clinical outcomes collected in SJLIFE.
Conditions Studied
Interventions
- OTHER Neurocognitive (Thinking) Testing
- DIAGNOSTIC_TEST CNS Vital Signs (Thinking) Testing
- OTHER Health Questionnaires, Sleep Surveys & Sleep Diary
- DIAGNOSTIC_TEST Echocardiography/EKG
- DIAGNOSTIC_TEST Pulmonary Function
Study Locations (1)
Tennessee
- St. Jude Children's Research Hospital - Memphis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2023-04-17 |
| Est. Completion | 2027-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05480904
The ClinicalTrials.gov registry entry for NCT05480904 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 221-participant average among 196 other Solid Tumor trials with a reported enrollment target (46% lower). The listed sponsor is St. Jude Children's Research Hospital, which has 410 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Solid Tumor appearing as the primary indexed condition, and to 5 interventions - of which Neurocognitive (Thinking) Testing is the first listed.
NCT05480904 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.
Frequently Asked Questions
What is clinical trial NCT05480904 about?
NCT05480904 is a clinical study titled "Characterizing Sleep Among Long-term Survivors of Childhood Cancer". The patients are being asked to take part in this clinical trial because they received cancer treatment as a child at St. Jude. The study comprehensively examines sleep among three distinct diagnostic groups of survivors in the SJLIFE cohort: ALL, CNS tumors, and non-CNS solid tumors. Primary Objec...
What is the current status of trial NCT05480904?
This trial is currently recruiting. The enrollment target is 120 participants. The study started on 2023-04-17. Estimated completion is 2027-01.
What conditions does trial NCT05480904 study?
This clinical trial studies the following conditions: Solid Tumor, ALL, Adult, CNS Tumor.
What interventions are being tested in trial NCT05480904?
The interventions under investigation include: Neurocognitive (Thinking) Testing (OTHER), CNS Vital Signs (Thinking) Testing (DIAGNOSTIC_TEST), Health Questionnaires, Sleep Surveys & Sleep Diary (OTHER), Echocardiography/EKG (DIAGNOSTIC_TEST), Pulmonary Function (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05480904?
This trial is sponsored by St. Jude Children's Research Hospital, which has 410 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05480904 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Solid Tumor
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study to Evaluate Safety, Efficacy, and Pharmacokinetics in Participants With Advanced Solid Tumors
RECRUITING · Phase 1
-
Study of Induction PD-1 Blockade in Subjects With Locally Advanced Mismatch Repair Deficient Solid Tumors
RECRUITING · Phase 2
-
Dabrafenib and/or Trametinib Rollover Study
RECRUITING · Phase 4
-
An Extension Study for Patients Previously Enrolled in Studies With Pelabresib
RECRUITING · Phase 3
-
A Phase I Study of ROSE12 Alone and in Combination With Other Anti-tumor Agents in Patients With Solid Tumors
RECRUITING · Phase 1
-
Phase I Study of Tolododekin Alfa (ANK-101) in Advanced Solid Tumors
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.